Catalyst Wire Dossier Catalyst Wire Dossier

R935788

· Rigel Pharmaceuticals
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for R935788, covering 2012-04-30 to 2021-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) [Phase 2]

See pricing